Share This Link

Flush the IV catheter: Flushing the IV catheter could exacerbate infiltration by pushing more fluid into the surrounding tissue. It is not the appropriate action for managing infiltration and could worsen the client's condition.

Slow the infusion rate: Slowing the infusion rate is a reasonable action to reduce the flow of fluid into the tissues and minimize further infiltration. However, it may not be sufficient to manage existing infiltration effectively or prevent tissue damage.

Apply pressure to the IV site: Applying pressure to the IV site is not recommended for managing infiltration. It could cause further tissue damage and discomfort for the client and is not considered a standard practice in managing this complication.

A client vomits after receiving an oral medication: While vomiting after medication administration should be documented in the client's medical record as it could indicate a ’otential adverse reaction or medication intolerance, it does not necessarily require an incident report unless there are unusual circumstances surrounding the event.

A client receives their meal tray 20 minutes before time: This situation does not require an incident report. It may be considered a minor deviation from the usual mealtime schedule, and no harm or adverse outcome is implied.

A client experiences a seizure: While a client experiencing a seizure is a critical event that requires immediate nursing intervention and documentation, it does not typically warrant an incident report unless it occurs in unusual circumstances or if there are concerns about the client's safety or well-being during the seizur’.

Insomnia: While insomnia can be a side effect of some medications, it is not commonly associated with carbamazepine. Therefore, it is not a priority adverse effect for the client to monitor.

Tachypnea: Tachypnea, or rapid breathing, is not typically associated with carbamazepine use. While respiratory depression is a concern with some medications, it is not a common adverse effect of carbamazepine.

Metallic taste: Metallic taste is a less common adverse effect of carbamazepine. While it may occur, it is not as prevalent or significant as blurred vision, which can impact the client's daily activities and safety.

Aspirate the syringe prior to injecting the heparin: Aspiration is not necessary for subcutaneous injections, as the risk of intravascular injection is minimal. Aspirating the syringe can increase discomfort for the client and is not recommended for subcutaneous injections.

Use the Z-track method to administer the medication: The Z-track method is used for intramuscular injections to minimize medication leakage into the subcutaneous tissue. However, heparin is typically administered subcutaneously, and the Z-track method is not appropriate for this route of administration.

Gently massage the site following the injection: Massaging the site following a subcutaneous injection of heparin can increase the risk of bleeding and hematoma formation. Therefore, this action should be avoided to minimize bleeding at the injection site.

Hypertension: Amiodarone is not typically associated with hypertension. Instead, it is more commonly associated with hypotension.

Bradypnea: Amiodarone is not typically associated with bradypnea. Instead, it is more commonly associated with pulmonary toxicity, which can manifest as cough, dyspnea, and pulmonary fibrosis.

Fever: While fever is a possible adverse effect of amiodarone, it is not one of the most commonly observed adverse effects. Other adverse effects, such as thyroid dysfunction, pulmonary toxicity, and hepatic toxicity, are more frequently reported.

Notify the nurse manager about the incident: While it's important to report medication errors,’the immediate concern should be the client's well-being. Notifying the nurse manage’ can be done after addressing the client's condition.

Prepare and file an inc’dent report: Filing an incident report is necessary to document the error, but it should not be the first action taken. Ensuring the client's safety and well-being is the priority.’

Notify the provider of the medication administration: While it's important for the provider to be infor’ed of medication errors, the immediate concern should be assessing the client's response to the medication.

A. Return the remaining medication to the facility's pharmacy:
Returning unused medication to the pharmacy is a common practice; however, it typically applies to unopened or excess stock. In this case, the medication has been partially administered, and returning it is not appropriate. The facility may have specific protocols regarding handling partial doses of controlled substances.

C. Store the remaining half of the pill in the automated medication dispensing system:
Storing partial doses in the automated dispensing system is not permitted. This could lead to confusion regarding dosing and may violate policies on medication management, especially for controlled substances.

D. Place the remaining half of the pill in the unit-dose package:
Repackaging leftover medication is inappropriate for controlled substances due to the risk of misadministration and tracking issues. This could also violate safety regulations, as it complicates accountability for medication use.

Increased energy: While increased energy could be a positive outcome of treatment, it is not a specific indicator of the client's response to spironolactone therapy for’cirrhosis.

Increased appetite: Increased appetite is not typically a direct response to spironolactone therapy for cirrhosis. It may be influenced by various factors and is not specific to the client's response to the medication.

Decrea’ed jaundice: While spironolactone may indirectly help improve liver function, decrease fluid retention, and alleviate symptoms of cirrhosis, it is not primarily used to address jaundice. Other interventions and treatments may be necessary to manage jaundice in clients with liver cirrhosis.

Valerian: While valerian is an herbal supplement used for its sedative effects, it does not typically interact significantly with warfarin. However, caution should still be exercised when combining valerian with any medication due to its potential to cause drowsiness and enhance the effects of other central nervous system depressants.

Coenzyme Q10: Coenzyme Q10 is a dietary supplement that is generally well-tolerated and does not have significant interactions with warfarin. It is often used as an antioxidant and for various cardiovascular conditions.

Probiotics: Probiotics are beneficial bacteria that can aid in gut health but are unlikely to interact significantly with warfarin. However, it is essential to monitor for any potential changes in gastrointestinal function when starting probiotics concurrently with warfarin.